Top Markets
Coin of the day
BioAge Labs Inc. BioAge Labs Inc.

BioAge Labs Inc.

BIOA
Hisse Senetlerindeki Sıralama #15446
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops... BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Hisse Fiyatı
$9.42
Piyasa Değeri
$354.69M
Değişim (1 gün)
-0.83%
Değişim (1 yıl)
91.09%
Ülke
US
Ticaret BioAge Labs Inc. (BIOA)

Kategori

BioAge Labs Inc. (BIOA) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $9.50 - 2026-09-01

Gün sonu en düşük fiyat: $20.04 - 2024-09-01
BioAge Labs Inc. için hisse fiyatı geçmişi: 2024 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 19.87%
2025 48.86%
2024 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$548.98 40.40%
US
$1.03K 44.32%
NL
$121.37 -11.93%
AU
$144.39 499.38%
US
$748.60 4.92%
CH